Axinn partner Jeny Maier co-hosted ABA's Our Curious Amalgam podcast in an episode entitled, "Are PBMs Good For Competition? A Cost-Benefit Analysis of the Effects of Regulating Pharmacy Benefit Managers.”

Jeny spoke with Professor Casey Mulligan, an economist and law professor at the University of Chicago, and he discussed what his research indicates could be the unintended adverse consequences of imposing transparency requirements and other regulatory burdens on PBMs.

Click here to access the episode